Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01606709Phase 4Terminated
A Phase 4 trial of leuprolide in ovarian hyperstimulation syndrome (OHSS), sponsored by UConn Health. Started Apr 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01606709.